Antherieu, G.; Bidet, A.; Huet, S.; Hayette, S.; Migeon, M.; Boureau, L.; Sujobert, P.; Thomas, X.; Ghesquières, H.; Pigneux, A.;
et al. Allogenic Stem Cell Transplantation Abrogates Negative Impact on Outcome of AML Patients with KMT2A Partial Tandem Duplication. Cancers 2021, 13, 2272.
https://doi.org/10.3390/cancers13092272
AMA Style
Antherieu G, Bidet A, Huet S, Hayette S, Migeon M, Boureau L, Sujobert P, Thomas X, Ghesquières H, Pigneux A,
et al. Allogenic Stem Cell Transplantation Abrogates Negative Impact on Outcome of AML Patients with KMT2A Partial Tandem Duplication. Cancers. 2021; 13(9):2272.
https://doi.org/10.3390/cancers13092272
Chicago/Turabian Style
Antherieu, Gabriel, Audrey Bidet, Sarah Huet, Sandrine Hayette, Marina Migeon, Lisa Boureau, Pierre Sujobert, Xavier Thomas, Hervé Ghesquières, Arnaud Pigneux,
and et al. 2021. "Allogenic Stem Cell Transplantation Abrogates Negative Impact on Outcome of AML Patients with KMT2A Partial Tandem Duplication" Cancers 13, no. 9: 2272.
https://doi.org/10.3390/cancers13092272
APA Style
Antherieu, G., Bidet, A., Huet, S., Hayette, S., Migeon, M., Boureau, L., Sujobert, P., Thomas, X., Ghesquières, H., Pigneux, A., & Heiblig, M.
(2021). Allogenic Stem Cell Transplantation Abrogates Negative Impact on Outcome of AML Patients with KMT2A Partial Tandem Duplication. Cancers, 13(9), 2272.
https://doi.org/10.3390/cancers13092272
